Cost Effectiveness of Saxagliptin and Metformin versus Sulfonylurea and Metformin in the Treatment of Type 2 Diabetes Mellitus in Germany: A Cardiff Diabetes Model Analysis

Author： Erhardt Wilma  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.32, Iss.3, 2012-03, pp. : 189-202

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metformin ++ saxagliptin for type 2 diabetes

By Scheen André J  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 1, 2012-01 ,pp. : 139-146

Informa Healthcare

Access to resources Recommend Favorite

Combination of glibenclamide–metformin HCl for the treatment of type 2 diabetes mellitus

By Lamos Elizabeth Mary   Stein Stephanie Aleskow   Davis Stephen N  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 17, 2012-12 ,pp. : 2545-2554

Informa Healthcare

Access to resources Recommend Favorite

Metformin extended release for the treatment of Type 2 diabetes mellitus

By Schwartz Sherwyn L   Wu Jacqueline F   Berner Bret  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 6, 2006-04 ,pp. : 803-809

Informa Healthcare

Access to resources Recommend Favorite

An Economic Evaluation of Colesevelam when Added to Metformin-, Insulin- or Sulfonylurea-Based Therapies in Patients with Uncontrolled Type 2 Diabetes Mellitus

By Simons W. Robert   Hagan Michael A.  

PharmacoEconomics, Vol. 28, Iss. 9, 2010-09 ,pp. : 765-780

Adis International

Access to resources Recommend Favorite

Exenatide: A Review of Its Use in Patients with Type 2 Diabetes Mellitus (as an Adjunct to Metformin and/or a Sulfonylurea)

By Cvetković Risto S.   Plosker Greg L.  

Drugs, Vol. 67, Iss. 6, 2007-01 ,pp. : 935-954

Adis International

Access to resources Recommend Favorite